Royalty Pharma: Post Q3 Earnings, We Reiterated Our Strong Buy (NASDAQ:RPRX)
By Press Room
3 Mins read
In September end, we decided to initiate coverage of Royalty Pharma plc (NASDAQ:RPRX), and today, the company released its quarterly figures. Solid…
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Not that…
Since Hamas attacked Israel on Oct. 7, the stock market has largely shrugged off the escalating conflict, but some businesses are certainly…
Unilever maintains investor confidence despite CEO transition and strategy skepticism
By Press Room
1 Mins read
© Reuters. Amidst a period of substantial transformation for Unilever (LON:) (NYSE: UL), investor sentiment remains optimistic even as Wall Street shows…
By Karen Brettell NEW YORK (Reuters) – The dollar dipped against the euro on Friday but gained against the yen as investors…
Source: AdobeStock / Jimmy Tudeschi The highly anticipated Grand Theft Auto (GTA) VI is coming – but will it come with an…
By Breakingviews For Compagnie Financiere Richemont, not all that glitters is gold. The $65 billion owner of jeweler Cartier finally agreed to…
‘A normal guy’: Argentina’s radical Milei struggles to rebrand for run-off vote
By Press Room
4 Mins read
Libertarian economist Javier Milei powered through the early stages of Argentina’s presidential election on the strength of a radical plan, an eccentric…
Home prices keep going up, defying mortgage rates at 23-year highs and a housing market that hasn’t been this unaffordable since the…
House Republicans unveiled a stopgap plan for funding the federal government on Saturday, giving Congress just under a week to pass legislation…